We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
(+5.6%)
Cap. Flow
-$90.2M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivePerson
LPSN
|
+$4.19M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$4.14M |
| 3 |
TBCH
Turtle Beach Corp
TBCH
|
+$4.13M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$4.07M |
| 5 |
Tactile Systems Technology
TCMD
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$6.81M |
| 2 |
CUTR
Cutera, Inc.
CUTR
|
+$4.92M |
| 3 |
Vericel Corp
VCEL
|
+$4.77M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.75M |
| 5 |
INST
Instructure, Inc.
INST
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Technology | 24.9% |
| 3 | Consumer Discretionary | 14.4% |
| 4 | Industrials | 10.81% |
| 5 | Financials | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBCH
1
Turtle Beach Corp
TBCH
$242M
| $6.67M | 1.05% |
+328,478
| New | +$4.13M |
|
2
Madrigal Pharmaceuticals
MDGL
$12.6B
| $5.74M | 0.9% |
20,506
-7,438
| -27% | -$1.31M |
|
|
CTLP
3
DELISTED
Cantaloupe
CTLP
| $5.28M | 0.83% |
376,754
-147,388
| -28% | -$1.68M |
|
|
TRHC
4
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.15M | 0.81% |
80,668
-62,373
| -44% | -$3.06M |
|
|
NVTR
5
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $5.04M | 0.79% |
+245,287
| New | +$4.14M |
|
|
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.91M | 0.77% |
99,656
+38,626
| +63% | +$1.46M |
|
|
7
Tactile Systems Technology
TCMD
$625M
| $4.84M | 0.76% |
+93,095
| New | +$4.05M |
|
8
Sunrun
RUN
$2.41B
| $4.76M | 0.75% |
362,050
+233,217
| +181% | +$2.53M |
|
|
9
LivePerson
LPSN
$19.5M
| $4.69M | 0.74% |
+14,807
| New | +$4.19M |
|
|
BEAT
10
DELISTED
BioTelemetry, Inc.
BEAT
| $4.59M | 0.72% |
+102,013
| New | +$4.07M |
|
11
Rapid7
RPD
$638M
| $4.46M | 0.7% |
158,211
-16,585
| -9% | -$493K |
|
12
iRhythm Holdings
IRTC
$3.58B
| $4.46M | 0.7% |
55,028
-13,858
| -20% | -$969K |
|
|
EVBG
13
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $4.46M | 0.7% |
94,132
-30,094
| -24% | -$1.28M |
|
|
SIEN
14
DELISTED
Sientra, Inc.
SIEN
| $4.43M | 0.7% |
+22,699
| New | +$3.6M |
|
15
Tandem Diabetes Care
TNDM
$1.17B
| $4.41M | 0.7% |
+200,187
| New | +$2.46M |
|
|
ROCC
16
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $4.37M | 0.69% |
+51,506
| New | +$3.09M |
|
17
AngioDynamics
ANGO
$564M
| $4.35M | 0.69% |
+195,553
| New | +$4M |
|
|
CARB
18
DELISTED
Carbonite Inc
CARB
| $4.33M | 0.68% |
124,194
-13,139
| -10% | -$451K |
|
19
Comtech Telecommunications
CMTL
$53.9M
| $4.3M | 0.68% |
134,881
-14,148
| -9% | -$441K |
|
20
McGrath RentCorp
MGRC
$2.94B
| $4.29M | 0.68% |
67,817
+46,441
| +217% | +$2.86M |
|
|
GLUU
21
DELISTED
Glu Mobile Inc.
GLUU
| $4.26M | 0.67% |
+664,878
| New | +$3.46M |
|
|
TPIC
22
DELISTED
TPI Composites
TPIC
| $4.22M | 0.67% |
+144,463
| New | +$3.65M |
|
23
AtriCure
ATRC
$1.7B
| $4.2M | 0.66% |
+155,411
| New | +$3.65M |
|
24
Malibu Boats
MBUU
$543M
| $4.2M | 0.66% |
100,171
+76,634
| +326% | +$3.06M |
|
25
Etsy
ETSY
$7.68B
| $4.18M | 0.66% |
99,021
-29,736
| -23% | -$968K |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2018 Portfolio in Review
As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.
- EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
- EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
- EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
- EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
- EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
- EAM Investors opened 130 new positions and closed 127 in Q2 2018.
- EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.
Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.